ClinicalTrials.gg
RecruitingNCT06559852Updated Oct 6, 2026

The Impact of Yoga on Endometriosis-Related Pain

An interventional study of Yoga in Endometriosis, sponsored by Milton S. Hershey Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Milton S. Hershey Medical Center · Not applicable, Interventional, and Treatment

How we know · 2 judgments

Updated Oct 6, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 169 studies in Endometriosis with a site in United States — 38 open to participants now, 48 under way, 5 of them phase 3. Endometriosis · United States.

Planned enrollment
81st of 131
30 · median 60
Started
2026
with 14 others
No phase
39 of 169
12 open now
Primary completion
2027-03
later than 14 of 47 live
Registered
142nd of 169
by date
Lead sponsor
8 of 169
Milton S. Hershey Medical Center

Among the 169 studies in Endometriosis with a site in United States, this one is the 81st largest by planned enrollment of the 131 interventional ones that give a count, is one of 15 that started in 2026, is one of 39 with no phase, reaches primary completion later than 14 of the 47 other live ones, and was the 142nd registered.

Endometriosis

924 studies on the registry are indexed under Endometriosis; 268 are open to participants now.

Browse Endometriosis studies →

Open to participants now

38 of the 169 studies in Endometriosis with a site in United States are open now. Recruiting first, the newest first:

32 more — sign in →

All 38 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 180 Endometriosis studies recruiting now, 53 (29%) set no upper age limit and 125 (69%) stop at 75 or younger; 18 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 169 studies in Endometriosis with a site in United States, or all of them as a file.
02

Study summary

The central hypothesis of the investigators is that the practice of yoga will result in an improvement of endometriosis related pain symptoms for women with endometriosis.

Read the detailed description

Yoga has been demonstrated to improve menstrual pain associated with primary dysmenorrhea through use of physical exercises, mental meditation, and breathing techniques. Still, there has been limited studies assessing potential benefits of yoga on pain symptoms of endometriosis. It is important to further assess yoga as a complementary therapy for women with endometriosis.

03

Conditions studied

  • Endometriosis

Keywords

  • Pelvic Pain
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Reproductive aged women 18-45
  2. Self-reported prior surgery with pathology confirming a diagnosis of endometriosis
  3. No current use of yoga
  4. Baseline moderate pain, score greater than or equal to 5 on VAS scoring
  5. Access to internet with wifi capability for zoom platform and completion of weekly surveys
  6. Access to items required for yoga session participation (2 blankets or towels, firm pillow, stable chair, wall space, comfortable clothing, water)
  7. Ability to commit to duration of 12-week yoga course

Exclusion criteria

Exclusion Criteria:

  1. Pregnant patients
  2. Established yoga participation or moderate exercise regimen
  3. Physical trauma or disability
  4. Planned surgery or hormonal medication change during study
  5. Non-English speaking patients
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Yoga Intervention

    Behavioral: Yoga

Interventions

  • BehavioralYoga

    Participants will engage in a 12-week virtual yoga course to assess impact on endometriosis-related pain

06

What researchers measure

Primary outcomes

  1. Change in Endometriosis Health Profile-30 Pain Score

    Identify the impact of yoga on endometriosis related pain based on the Endometriosis Health Profile-30, with specific focus on the domain of pain. The EHP-30 questionnaire consists of five scales which includes pain, control and powerlessness, emotional well-being, social support, and self-image and a total of 30 questions. Each scale is translated into a score ranging from 0, or the best health status, to 100, the worst health status.

    Time frame: Baseline to completion at 12-weeks

Secondary outcomes

  1. Change in Visual Analog Scale scores

    Comparison of visual analog scale scores from start to the end of the study. The visual analog scale is a validated scale for measuring acute and chronic pain. Scores are recorded on a scale between 0 or "no pain" and 10, the "worst pain".

    Time frame: Baseline to completion at 12-weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Plan to publish in an ICMJE journal upon completion of study.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Mar 2027, 5 months later.

Of 199 non-industry interventional studies with no phase under Endometriosis, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 44. This study's planned 5 months is below that.

Counting every sponsor, half of 214 studies reached it within 25 months; a quarter within 13 and three quarters within 44.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: start Aug 2026 → Oct 2026, primary completion Sep 2026 → Mar 2027 and completion Sep 2026 → Apr 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2024
First posted
Aug 19, 2024
StartEst.
Oct 15, 2026was Aug 2026
Primary completionEst.
Mar 30, 2027was Sep 2026
CompletionEst.
Apr 30, 2027was Sep 2026
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 15, 2026→Oct 15, 2026
Oct 6, 2026
Primary completion
Sep 15, 2026→Mar 30, 2027
Oct 6, 2026
Study completion
Sep 15, 2026→Apr 30, 2027
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    Start date Aug 15, 2026→Oct 15, 2026
    Primary completion Sep 15, 2026→Mar 30, 2027
    Study completion Sep 15, 2026→Apr 30, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06559852
Responsible party
Linda Li (Assistant Professor, Department of Obstetrics and Gynecology, Milton S. Hershey Medical Center) — Principal investigator
First posted
Aug 19, 2024
Start date
Oct 15, 2026 (estimated)
Primary completion
Mar 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Oct 6, 2026

Study contacts

Linda Li, MD
Contact
lindali@pennstatehealth.psu.edu
7175313503
Ashlie Carter, MD
Contact
acarter8@pennstatehealth.psu.edu
7175313503

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion